PDCD1 and lung cancer: Pulmonary sarcomatoid carcinoma (SC) is an aggressive subtype of lung cancer that exhibits resistance to cytotoxic chemotherapy and the efficacy of combined therapy with PD‐1 inhibitor plus cytotoxic chemotherapy as first‐line treatment has not previously been clarified.